Voyager Therapeutics: Peers

The FY2025 (Dec) proxy of Voyager Therapeutics names 18 peer companies for pay. Among Voyager Therapeutics and these peers, CEO pay was 4th highest of 6 and total shareholder return was 4th highest of 6.

4th highest of 6in Voyager Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:

$2.1M$8.3M

4th highest of 6in Voyager Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:

$23$202

Pay peer group, FY2025 (Dec) proxy

MeiraGTx Holdings
Solid Biosciences
Neurogene
Editas Medicine
4D Molecular Therapeutics
Adverum Biotechnologies, Inc.Not disclosedNot disclosed
Entrada TherapeuticsNot disclosedNot disclosed
Foghorn TherapeuticsNot disclosedNot disclosed
Lexeo TherapeuticsNot disclosedNot disclosed
Monte Rosa TherapeuticsNot disclosedNot disclosed
PepGen, Inc.Not disclosedNot disclosed
Prelude Therapeutics Inc.Not disclosedNot disclosed
Prime MedicineNot disclosedNot disclosed
Stoke TherapeuticsNot disclosedNot disclosed
Tenaya Therapeutics, Inc.Not disclosedNot disclosed
Verve Therapeutics, Inc.Not disclosedNot disclosed
Vigil Neuroscience, Inc.Not disclosedNot disclosed
Wave Life SciencesNot disclosedNot disclosed
18 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.